CAS 203395-59-9

Aripiprazole Bromobutoxyquinolinone Analog (7-(4-bromobutoxy)quinolin-2(1H)-one)

CAS: 203395-59-9

Lactams, nesoi

Formel: C₁₃H₁₄BrNO₂

Farbe und Form: White Off-White Solid

Molekulargewicht: 295.02079

Ref: 45-1A02480

7-(4-Bromobutoxy)-quinoline-2(1h)-one

CAS: 203395-59-9

Formel: C₁₃H₁₄BrNO₂

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 296.1598

Ref: IN-DA0028V5

Aripiprazole Impurity 41

CAS: 203395-59-9

Formel: C₁₃H₁₄BrNO₂

Farbe und Form: White To Off-White Solid

Molekulargewicht: 296.16

Ref: 4Z-A-1418

7-(4-Bromobutoxy)quinolin-2(1H)-one

CAS: 203395-59-9

7-(4-Bromobutoxy)quinolin-2(1H)-one

Reinheit: 95%

Molekulargewicht: 296.16g/mol

Ref: 54-OR95887

7-(4-Bromobutoxy)-2(1H)-quinolinone

CAS: 203395-59-9

Farbe und Form: Neat

Ref: 86-MM0961.20

Brexpiprazole Impurity 28

CAS: 203395-59-9

Formel: C₁₃H₁₄BrNO₂

Molekulargewicht: 296.16

Ref: ST-EA-CP-B15017

7-(4-Bromobutoxy)quinolin-2(1H)-one

CAS: 203395-59-9

Formel: C₁₃H₁₄BrNO₂

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 296.164

Ref: 10-F516397

7-(4-Bromobutoxy)-quinoline-2(1H)-one

Kontrolliertes Produkt

CAS: 203395-59-9

Formel: C₁₃H₁₄BrNO₂

Farbe und Form: Neat

Molekulargewicht: 296.16

Ref: TR-B681980

7-(4-Bromobutoxy)-quinoline-2(1H)-one

CAS: 203395-59-9

7-(4-Bromobutoxy)-quinoline-2(1H)-one is a chemical compound that is used as a chemical intermediate in the synthesis of other pharmaceuticals. It is synthesized by a convergent method starting from 4-bromo-2-butanone and piperazine. This process involves three steps: 1) the bromination of 4-bromo-2-butanone, 2) the reaction of the resulting bromide with piperazine to form 7-(4-bromobutoxy)-piperazinium chloride, and 3) the subsequent hydrolysis of this product to produce 7-(4-bromobutoxy)-quinoline-2(1H)-one. The trifluoromethanesulfonic acid catalyst is used for these reactions.

Formel: C₁₃H₁₄BrNO₂

Reinheit: Min. 95%

Molekulargewicht: 296.16 g/mol

Ref: 3D-FB19205